Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 12, 2009, Pages 1609-1619

  Filicko O'Hara, Joanne ^a   Grosso, Dolores ^a   Flomenberg, Phyllis R ^a   Friedman, Thea M ^a   Brunner, Janet ^a   Drobyski, William ^a   Ferber, Andres ^a   Kakhniashvili, Irina ^a   Keever Taylor, Carolyn ^a   Mookerjee, Bijoyesh ^a   Talano, Julie An ^a   Wagner, John I ^a   Korngold, Robert ^a   Flomenberg, Neal ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Donor lymphocyte infusion; Hematopoietic progenitor cell transplant; Immune reconstitution opportunistic infection

Indexed keywords

CIDOFOVIR; CYTARABINE; FLUDARABINE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; LEUCYLLEUCINE METHYL ESTER; MELPHALAN; RITUXIMAB; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; ADJUVANT THERAPY; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OPPORTUNISTIC INFECTION; T CELL DEPLETION; VIRUS INFECTION; VIRUS REACTIVATION;

ADULT; AGED; COHORT STUDIES; DIPEPTIDES; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 70350459268     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.08.020     Document Type: Article

References (41)

1. Champlin R., Khouri I., and Giralt S. Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases. J Clin Apheresis 14 (1999) 45-49
2. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
3. Forman S.J. Innovations in autologous transplantation for hematologic malignancy. Biol Blood Marrow Transplant 11 (2005) 28-33
4. Thomas E.D. Bone marrow transplantation from bench to bedside. Ann N Y Acad Sci 770 (1995) 34-41
5. Thomas E.D. History, current results, and research in marrow transplantation. Perspect Biol Med 38 (1995) 230-237
6. Couriel D.R., Saliba R.M., Giralt S., et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant 10 (2004) 178-185
7. Lee S.J. New approaches for preventing and treating chronic graft-versus-host disease. Blood 105 (2005) 4200-4206
8. Peggs K.S., and Mackinnon S. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy. Hum Immunol 65 (2004) 550-557
9. Riddell S.R., and Greenberg P.D. Cellular adoptive immunotherapy after bone marrow transplantation. Cancer Treat Res 76 (1995) 337-369
10. Hromas R., Cornetta K., Srour E., Blanke C., and Broun E.R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84 (1994) 1689-1690
11. Witt V., Fritsch G., Peters C., Matthes-Martin S., Ladenstein R., and Gadner H. Resolution of early cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor. Bone Marrow Transplant 22 (1998) 289-292
12. Papadopoulos E.B., Ladanyi M., Emanuel D., et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330 (1994) 1185-1191
13. Chakrabarti S., Milligan D.W., Pillay D., et al. Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. Blood 102 (2003) 839-842
14. Shouval D., and Ilan Y. Immunization against hepatitis B through adoptive transfer of immunity. Intervirology 38 (1995) 41-46
15. Shouval D., and Ilan Y. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. J Hepatol 23 (1995) 98-101
16. Lamb Jr. L.S., Gee A.P., Henslee-Downey P.J., et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors. Bone Marrow Transplant 21 (1998) 461-471
17. Dazzi F., and Goldman J.M. Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu Rev Med 49 (1998) 329-340
18. Dazzi F., Szydlo R.M., and Goldman J.M. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 27 (1999) 1477-1486
19. Bollard C.M., Kuehnle I., Leen A., Rooney C.M., and Heslop H.E. Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant 10 (2004) 143-155
20. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333 (1995) 1038-1044
21. O'Reilly R.J., Small T.N., Papadopoulos E., Lucas K., Lacerda J., and Koulova L. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol 20 (1998) 455-491
22. Liu Z., Savoldo B., Huls H., et al. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas. Rec Results Cancer Res 159 (2002) 123-133
23. Thiele D.L., and Lipsky P.E. The action of leucyl-leucine methyl ester on cytotoxic lymphocytes requires uptake by a novel dipeptide-specific facilitated transport system and dipeptidyl peptidase I-mediated conversion to membranolytic products. J Exp Med 172 (1990) 183-194
24. Thiele D.L., and Lipsky P.E. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci USA 87 (1990) 83-87
25. Thiele D.L., and Lipsky P.E. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol 136 (1986) 1038-1048
26. Rosenfeld C.S., Thiele D.L., Shadduck R.K., Zeigler Z.R., and Schindler J. Ex vivo purging of allogeneic marrow with L-Leucyl-L-leucine methyl ester. A phase I study. Transplantation 60 (1995) 678-683
27. Pecora A.L., Bordignon C., Fumagalli L., et al. Characterization of the in vitro sensitivity of human lymphoid and hematopoietic progenitors to L-leucyl-L-leucine methyl ester. Transplantation 51 (1991) 524-531
28. Kakhniashvili I., Filicko J., Kraft W.K., and Flomenberg N. Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 11 (2005) 609-618
29. Hameed A., Olsen K.J., Cheng L., Fox III W.M., Hruban R.H., and Podack E.R. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 140 (1992) 1025-1030
30. Hsieh M.H., Varadi G., Flomenberg N., and Korngold R. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk. Biol Blood Marrow Transplant 8 (2002) 303-315
31. Olive M., Eisenlohr L.C., and Flomenberg P. Quantitative analysis of adenovirus-specific CD4 + T-cell responses from healthy adults. Viral Immunol 14 (2001) 403-413
32. Nitsche A., Oswald O., Steuer N., et al. Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development?. Clin Chem 49 (2003) 1683-1685
33. Griscelli F., Barrois M., Chauvin S., Lastere S., Bellet D., and Bourhis J.H. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 39 (2001) 4362-4369
34. Kearns A.M., Guiver M., James V., and King J. Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus. J Virol Methods 95 (2001) 121-131
35. Yoshida A., Hitomi S., Fukui T., et al. Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real-time PCR assay. Clin Infect Dis 33 (2001) 1756-1761
36. Vats A., Shapiro R., Singh Randhawa P., et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 75 (2003) 105-112
37. Randhawa P., Ho A., Shapiro R., et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 42 (2004) 1176-1180
38. van Esser J.W., Niesters H.G., Thijsen S.F., et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 113 (2001) 814-821
39. van Esser J.W., van der Holt B., Meijer E., et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98 (2001) 972-978
40. Friedman T.M., Varadi G., Hopely D.D., et al. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches. Biol Blood Marrow Transplant 7 (2001) 656-664
41. Friedman T.M., Filicko-O'Hara J., Mookerjee B., et al. T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions. Biol Blood Marrow Transplant 13 (2007) 1439-1447